24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Recognizing a Staph InfectionIs Dairy Fat Different?CDC Recommends Catch-Up HPV Vaccination for Young AdultsHow to Relieve Dry, Irritated EyesPretomanid Approved for Treatment of Drug-Resistant TBAHA News: Tiring Easily May Warn of Future Heart TroubleAmerica's Obesity Epidemic May Mean Some Cancers Are Striking SoonerHeavy Smog as Bad as Pack-a-Day Smoking for LungsConcussed NFL Players Sidelined for Much Longer NowadaysHormone Therapy for Prostate Cancer Might Harm the Heart: StudyObesity and 'Spare Tire' Raise Hispanics' Odds for Early DeathAHA News: Protein Made During Long Workouts May Warn of Heart ProblemsHow to Help Your Heart Weather Extreme HeatHealth Threats Don't End for Some Sepsis SurvivorsHeat Waves Brought by Climate Change Could Prove Deadly for Kidney PatientsHealth Tip: Avoiding AnemiaAre You Still Putting Off Colon Cancer Screening?Tips for Preventing DiverticulitisFDA Reports More Seizures Among VapersKids Getting Too Many Opioids After TonsillectomyCan Major Surgeries Cause a Long-Term 'Brain Drain'?How Much Coffee Is Too Much for Migraine Sufferers?Steady Stream of Lesser Head Hits in Football Can Still Damage BrainDon't Sweat It: Hyperhydrosis Can Be TreatedFast-Food Joints on Your Way to Work? Your Waistline May WidenAdults Need Vaccines, TooHealth Tip: Managing Arthritis of the Hands'Selfies' Might Someday Track Your Blood PressureIn Heat Waves, Fans May Do More Harm Than GoodSmoking Creates Long-Lasting Risk for Clogged Leg ArteriesFootball Head Trauma Linked Again to Long-Term Brain DamageDrug Approved to Treat Tenosynovial Giant Cell TumorRugby-Style Tackling Might Make Football SaferFor Kids With Asthma, Allergies, New School Year Can Bring Flare-UpsFrailty Not a Normal Part of AgingAHA News: Hurricane Checklist: Batteries, Bottled Water – And A Plan for Heart CareDangerous Sesame Allergy Affects Many AmericansScorching Pavement Sends Some to the ER With BurnsHealth Tip: Living With Hypoglycemia3-D Printers Might Someday Make Replacement HeartsCDC Renews Pledge to Fight Ebola Outbreak in AfricaAnemia Linked to Higher Odds for Dementia in SeniorsDrug Duo May Be an Advance Against a Common LeukemiaAHA News: Chemical Widely Used in Medical Plastic Alters Heart Function in Lab TestsHigh Blood Pressure Much More Deadly for the PoorHealth Tip: Understanding PrediabetesMild Head Injury Can Impair Your Sense of SmellMiddle Age Now a High-Risk Time for Bad FallsSmoking May Interfere With 'Embolization' Lung TreatmentHeartburn Drugs Might Bring Allergy Woes
Questions and AnswersLinks
Related Topics

Diabetes

For Many With Mild Asthma, Popular Rx May Not Work: Study

HealthDay News
by -- Robert Preidt
Updated: May 21st 2019

new article illustration

TUESDAY, May 21, 2019 (HealthDay News) -- A widely used type of asthma medication may not work in more than half of patients who are prescribed it, new research shows.

Inhaled corticosteroids, which are designed to reduce airway inflammation, are recommended for all patients with persistent asthma.

But this medication's effectiveness may be limited to a type of inflammation that occurs in far fewer patients than once thought, according to the researchers.

For the study, which was funded by the U.S. National Heart, Lung, and Blood Institute, investigators compared the use of an inhaled steroid called mometasone (Nasonex) to a placebo in 295 patients over 12 years of age with mild persistent asthma.

The patients were grouped according to the level of eosinophils (Eos), a type of white blood cell, in their phlegm. In all, 73% were "Eos low" -- about 50% more than the researchers expected. The remaining 27% were "Eos high."

Among those who were Eos low, there was no significant difference in response to mometasone versus the placebo. And about 66% did as well or better on the placebo, the findings showed.

Eos-high patients were nearly three times more likely to respond to the inhaled steroid than to the placebo (74% versus 26%), according to the study published May 19 in the New England Journal of Medicine.

One lung expert noted inhaled steroids have been used to treat asthma for decades.

"Aerosolized steroids revolutionized the treatment of asthma in the 1990s, and so it is curious to come upon a study wherein more than half of asthmatics studied responded to aerosolized steroid no better than placebo," said Dr. Len Horovitz, a pulmonary specialist with Lenox Hill Hospital in New York City. But he noted that accurately measuring Eos levels in the phlegm can be difficult.

The researchers also looked at use of a medication called tiotropium (Spiriva), which is prescribed along with inhaled steroids. Tiotropium relaxes the muscles that tighten around the airways in asthma.

Though there was not enough evidence to conclude that patients prescribed tiotropium are likely to do better, the results suggested that alternatives to inhaled steroids should be studied further, the researchers said.

"The take-home message is that many patients have a pattern of inflammation that makes them less likely to respond to inhaled steroids," explained study first author Dr. Stephen Lazarus. He's a professor in the division of pulmonary and critical care medicine at the University of California, San Francisco.

"Doctors should consider this if patients are not responding, rather than just increasing the dose," he suggested in a university news release.

More information

The U.S. Centers for Disease Control and Prevention has more on asthma.